Wellinq

What Wellinq does

Wellinq is a Netherlands-based medical device company headquartered in Leek that develops, manufactures, and markets catheter-based vascular solutions for cardiovascular and peripheral applications. The company sells two flagship product lines under its proprietary PendraCare brand: the Guiding catheter Primum (launched 2013, featuring a partial hydrophilic coating with uncoated distal and proximal segments) and the Angiographic catheter Pointer (launched 2009, featuring double wire stainless steel braiding and an atraumatic soft tip). Both product lines leverage proprietary braiding and surface-coating technologies and are supported by in-house manufacturing capabilities spanning extrusion, braiding, injection molding, laser cutting, ablation, coating, and assembly.

Beyond branded finished-goods sales, Wellinq operates an OEM and white-label business that allows partner medical device companies to launch catheter product lines under their own brands, with Wellinq serving as legal manufacturer carrying CE, FDA, and ISO 13485:2016 regulatory responsibility. The company also offers semi-finished catheter shafts for partners to complete locally (advantageous for tenders requiring local production), full contract manufacturing services, and end-to-end contract development from concept to commercial catheter device. Wellinq's PendraCare products are commercially available in more than 60 countries with regulatory registrations across Europe (MDD/MDR), the United States (FDA), Brazil (ANVISA), China (CFDA), and South Korea (KFDA).

In June 2023, Wellinq was acquired by India-based Translumina Therapeutics LLP as part of Translumina's strategy to expand its cardiovascular and endovascular product portfolio. Wellinq operates with 251–500 employees, with leadership under founder and CEO Floris Alkemade. The business is structured around four revenue streams: PendraCare branded sales, OEM/white-label, contract manufacturing, and semi-finished products, with no public pricing disclosed and sales conducted on a consultative email-based model.

Name

Wellinq

Legal name

Wellinq

Website

https://wellinq.com

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

251–500 employees

Short description

Wellinq is a Netherlands-based medical device manufacturer of cardiovascular catheters (guiding and angiographic), selling its own PendraCare brand plus OEM, white-label, semi-finished, and contract manufacturing services to medical device companies and distributors in 60+ countries.

Ownership category

akta.pro rank

Product category

Vascular Medical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT) (HLAHAFAI)

akta.pro secondary industry

Infusion Sets, Catheters & Pump Consumables (HLAHAIAH)

Keywords

• Cardiovascular catheters
• Catheter manufacturing
• Vascular medical devices
• OEM catheter solutions
• Minimally invasive devices

Headquarters

HQ city

Leek

HQ country

Netherlands

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Technology or R&D, Supply Chain, Infrastructure, Marketing or Sales

Revenue model

1. PendraCare Branded Product Sales: Wellinq markets finished catheter products under its own PendraCare brand, including Guiding catheters and Angiographic catheters. Products are commercially available in over 60 countries. Revenue is generated through direct sales to healthcare institutions and distributor networks.
2. OEM Solutions / White-label: Wellinq offers customers the option to label existing Wellinq products under their own brand. Wellinq can act as the legal manufacturer with full regulatory responsibility (CE and FDA registration), managing product responsibility and quality. This enables partner companies to launch catheter product lines without in-house manufacturing capability.
3. Contract Manufacturing (CMO Services): Wellinq serves as a contract manufacturing organization (CMO) for catheter-based products. The company offers process optimization, enhanced output, and automated production for partners. Services can be integrated with regulatory compliance support. Revenue is generated through long-term manufacturing service agreements.
4. Semi-finished Products: Wellinq provides semi-finished catheter products (shaft configurations for angiographic and guiding catheters) that customers complete in their own facilities. This enables local production, reduces costs (labor, transport, customs), and provides tender advantages due to local production. Revenue is generated through product sales of non-sterile, unfinished catheter components.
5. Contract Development Services: Wellinq provides comprehensive contract development services, guiding partners from product concept to a fully functional catheter device. Services include co-development, product enhancement, and catheter concept development, supported by in-house R&D, Clinical, QA/RA, production, and project management expertise. Seamlessly integrated with manufacturing support and regulatory compliance.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Core offering

Wellinq designs, develops, and manufactures cardiovascular catheters sold under its PendraCare brand (Primum Guiding Catheter and Pointer Angiographic Catheter), and supplies semi-finished catheter shafts, OEM/white-label manufacturing, and contract development services to medical device companies and distributors worldwide.

Product overview

Wellinq is a Netherlands-based medical device company specializing in catheter-based technologies with over 25 years of experience. The company's product portfolio centers on two main catheter lines: the Primum Guiding Catheter (launched 2013, available in 60+ countries) featuring unique partial hydrophilic coating for transradial procedures, and the Pointer Angiographic Catheter (launched 2009) with double wire stainless steel braiding for coronary interventions. Both product lines are commercialized under the PendraCare brand, with complementary Semi Finished Products enabling partners to complete local assembly. Beyond branded offerings, Wellinq provides Contract Development services (guiding clients from concept to functional device with R&D, regulatory, and clinical support) and Contract Manufacturing services (full in-house production capabilities including extrusion, braiding, injection molding, laser processing, coating, and assembly). The company also supports OEM solutions and white-label manufacturing.

Differentiator

Problem solved

Functional benefit

Brands

• PendraCare: The company's own brand for medical devices including Guiding catheters and Angiographic catheters. PendraCare is the legal manufacturer with ISO 13485 certification and regulatory registrations in Europe (MDD/MDR), FDA, ANVISA, CFDA, KFDA, and multiple country registrations.

Products and services

• Guiding catheter Primum A hydrophilic-coated guiding catheter with a unique partial hydrophilic coating (distal 7cm and proximal 25cm segments remain uncoated for alignment, backup support, and 1:1 torque control), featuring encapsulated ultra-thin high-strength flat wire braiding for kink resistance and high push ability. Used by interventional cardiologists in transradial PCI procedures and supported by ARCUS clinical study outcomes showing reduced vessel spasm.
• Angiographic catheter Pointer A 6 French angiographic catheter with a unique hydrodynamic hydrophilic surface for low friction in tortuous anatomy and calcified lesions, double wire stainless steel braiding for low kink resistance and 1-to-1 torque transfer, an atraumatic soft tip to reduce vessel damage, and large inner lumens available in 4F, 5F, and 6F sizes. Designed for coronary imaging and intervention procedures.
• Semi-finished Catheter Products Versatile catheter components including fully finished non-sterile packed products and customizable catheter shafts for Angiographic and Guiding catheters. Supplied to partners who complete final assembly in their own facilities, providing local production advantages for tenders, reduced transport/customs costs, and customization flexibility.
• Contract Manufacturing Services Comprehensive contract manufacturing services for catheter-based products with full in-house capabilities including extrusion, braiding, injection molding, laser cutting, ablation, coating, and assembly. Wellinq can act as legal manufacturer managing regulatory registrations such as CE and FDA on behalf of the partner, with services integrated with regulatory compliance support.
• Contract Development Services Full-service catheter product development from concept to a fully functional catheter device, including co-development, product enhancement, and catheter concept development. Supported by in-house R&D, Clinical, QA/RA, production, and project management expertise, with seamless integration of manufacturing support and regulatory compliance.

Quantifiable outcome

• Guiding catheter Primum demonstrated high eligibility for use in transradial PCI (TR-PCI), with high procedural success and low complication rate. Favorable short and long-term MACCE (Major Adverse Cardiac and Cerebrovascular Events) outcomes were observed in the ARCUS study.
• +1 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Terumo Medical: Terumo is a global medical device manufacturer with a leading interventional systems portfolio including guide wires, catheters, and access devices for cardiovascular procedures. Directly competes with Wellinq's Primum guiding catheter and Pointer angiographic catheter in cath lab settings, with similar OEM and contract manufacturing capabilities.
• Merit Medical Systems: Merit Medical manufactures and markets a broad portfolio of cardiology and peripheral vascular devices including diagnostic and guiding catheters, inflation devices, and access products. Directly comparable as a catheter specialist with both branded and OEM/contract manufacturing operations serving similar hospital customers.
• Asahi Intecc: Asahi Intecc is a Japanese medical device company specializing in guidewires, catheters, and braided/coiled components for interventional cardiology and peripheral vascular procedures. Comparable in scale and specialty focus, with strong proprietary braiding technology analogous to Wellinq's encapsulated ultra-thin flat-wire braiding.

Broad incumbents

• Cordis (Cardinal Health): Cordis is a long-established interventional cardiology and vascular device manufacturer with a broad catheter portfolio, now operating as part of Cardinal Health. Comparable product overlap with Wellinq's guiding and angiographic catheter lines, but at significantly larger scale and with deeper global field sales.
• Teleflex: Teleflex is a diversified medical device manufacturer with significant presence in interventional cardiology and vascular access, including diagnostic and guiding catheters. Comparable as a larger incumbent with overlapping cath lab product offerings and OEM-style manufacturing depth.
• B. Braun Melsungen: B. Braun is a global medical and pharmaceutical device company with an interventional vascular portfolio including angiography catheters and accessories. Comparable through its catheter manufacturing capabilities and global regulatory footprint, though it operates across a much broader product portfolio.
• Nipro Medical: Nipro is a Japanese-headquartered medical device manufacturer with interventional cardiology and dialysis product lines, including diagnostic and guiding catheters. Comparable through its catheter manufacturing for OEM partners and its focus on emerging market distribution similar to Wellinq's semi-finished product model.

Emerging players

• Integer Holdings: Integer Holdings is a contract development and manufacturing organization specializing in medical device outsourcing including catheter-based products. Comparable as a CMO competitor in the catheter contract manufacturing space, with similar capabilities around extrusion, braiding, and assembly for OEM partners.
• Freudenberg Medical: Freudenberg Medical is a contract manufacturer of medical devices including catheters and minimally invasive components. Comparable as a CMO/contract development peer competing for OEM catheter manufacturing engagements similar to Wellinq's contract manufacturing and contract development services.

Others

• Translumina Therapeutics: Translumina Therapeutics is the India-based interventional cardiology company that acquired Wellinq in June 2023 to expand its cardiovascular and endovascular portfolio. Relevant as Wellinq's parent company and primary strategic stakeholder, though it operates more as a customer and capital provider than a direct competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Wellinq